Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Shoulder Innovations Initiates Commercial Launch of InSet® Go Glenoid System: Reported by Orthopedics This Week, Shoulder Innovations completed the first surgical case and initiated a limited user release for its InSet® Go anatomic glenoid system, engineered to prevent rocking horse loosening via circumferential cortical rim seating while streamlining operative sequence efficiency and supporting augmented bone loss configurations.
• VB Spine to Feature xvision X2 AR Headset and Vulcan™ Spinal System at NASS 2026: Detailed by Orthopedics This Week, VB Spine announced plans to showcase its line-of-sight xvision X2 augmented reality navigation headset paired with the Vulcan™ spinal platform at NASS 2026, following more than 60 successful clinical procedures completed during its limited market release.
• SurGenTec Secures Exclusive Global License for Vantage™ Spinal Decompression System: Reported by Orthopedics This Week, SurGenTec entered an exclusive licensing agreement with Allevion Medical for the Vantage™ sterile single-use decompression system, integrating direct surgical illumination with depth-controlled bony resection for minimally invasive lumbar stenosis treatment.
• Costa Surgical ProRib Fixation System Cleared: Costa Surgical, Inc. secured FDA 510(k) clearance (K261892) for its ProRib Fixation System, indicated for chest wall reconstruction and surgical stabilization of rib fractures in trauma and extremity patients.
• Zimmer Biomet G7® Acetabular System Cleared: Zimmer Biomet received FDA 510(k) clearance (K261453) for its G7® Acetabular System, indicated for total hip arthroplasty procedures requiring acetabular component fixation.

DAILY ANNOUNCEMENTS BY CATEGORY

Joint Reconstruction

Shoulder Innovations, Inc. — Shoulder Innovations Initiates Commercial Launch of the InSet® Go Glenoid System

• Summary: Shoulder Innovations announced the initiation of a limited user release for the InSet® Go, its next-generation glenoid implant designed for anatomic total shoulder arthroplasty, following the successful completion of its first surgical case performed by Dr. Robert Gillespie at University Hospitals Cleveland Medical Center. Invented to address glenoid component loosening—the leading cause of anatomic shoulder failure—the InSet® platform seats the implant within a supportive circumferential cortical bone rim to eliminate rocking horse loosening, while InSet® Go streamlines the operative sequence to reduce procedural time and supports InSet® PLUS augmented configurations for severe bone loss.
• Key Details:
  • Device/System Name: InSet® Go Glenoid System
  • Status: Commercial Launch / Limited User Release
  • Clinical Significance: Preserves native vault bone and counters glenoid loosening via circumferential cortical rim seating, reducing surgical steps to optimize OR efficiency while providing augmented fixation options for retroverted or bone-deficient glenoid anatomy.
• Original Source: Orthopedics This Week

Surgical Robotics, AI & Navigation

VB Spine LLC — VB Spine to Feature xvision X2 Augmented Reality Headset and Vulcan™ Spinal System at NASS 2026

• Summary: VB Spine announced plans to showcase its xvision X2 augmented reality (AR) surgical navigation headset alongside its Vulcan™ Spinal System at the upcoming North American Spine Society (NASS) 41st Annual Meeting in San Antonio. The xvision X2 headset displays real-time 3D navigation guidance directly within the surgeon's field of view to eliminate attention shift away from the patient, with more than 60 clinical cases completed during its limited market release ahead of broader commercialization paired with the thoracolumbar Vulcan™ fixation platform.
• Key Details:
  • Device/System Name: xvision X2 Headset & Vulcan™ Spinal System
  • Status: Limited Market Release (>60 Cases Completed) / Commercial Showcase at NASS 2026
  • Clinical Significance: Delivers line-of-sight heads-up augmented reality navigation for open and minimally invasive thoracolumbar pedicle instrumentation, eliminating surgeon gaze redirection to remote monitors and enhancing screw trajectory precision in complex anatomy.
• Original Source: Orthopedics This Week

Spine & Orthobiologics

SurGenTec® — SurGenTec Enters Exclusive License Agreement with Allevion Medical for Vantage™ Spinal Decompression System

• Summary: SurGenTec entered into an exclusive licensing agreement with Allevion Medical for its patented Vantage™ spinal decompression technology, a sterile single-use system engineered for minimally invasive lumbar decompression procedures. Designed to treat lumbar spinal stenosis secondary to hypertrophic bone formation, Vantage™ combines single-use integrated surgical illumination with depth-controlled resection tools to perform targeted laminotomy and laminectomy under direct anatomical visualization without bulky retractors or sterile processing burdens.
• Key Details:
  • Device/System Name: Vantage™ Spinal Decompression System
  • Status: Exclusive Global Licensing Agreement
  • Clinical Significance: Enables direct-visualization, depth-controlled bony decompression for lumbar spinal stenosis through a minimally invasive, fully disposable workflow, eliminating hospital sterile reprocessing bottlenecks while sparing posterior musculature.
• Original Source: Orthopedics This Week

RECENTLY INDEXED FDA 510(k) & PMA CLEARANCES — ORTHOPAEDIC

Note: The openFDA database typically indexes clearances 2–4 weeks after the official decision date. Dates shown reflect the FDA decision date, not the indexing date.